V85-28886-71839
4 vaccinations
3 coded responses
16 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-03-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Dose 1 — Moderna
-
2021-03-29
Registered in v-safe
- 2021-03-29
- 2021-04-05
-
2021-04-12
Survey response — day 21, dose 1MedDRA: Chills, Decreased appetite, Diarrhoea, Disturbance in attention, Fatigue, Headache, Pain, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Tested positive for COVID, fatigue, headache, chills, difficulty focusing, body aches, loss of appetite, diarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-21
-
2021-04-30
Dose 2 — Moderna
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-14
- 2021-05-28
- 2021-08-01
- 2021-10-30
-
2021-12-10
Dose 3 — Moderna
-
2022-05-02
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Got COVID againMedDRA releases: 2024-11 · check-in free text available
-
2022-05-02
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-03
-
2022-11-05
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-12-02
Survey response — day 21, dose 4MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Tested positive for COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Report sent to call center — day 21, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-03
- 2022-12-05
- 2022-12-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Moderna | |
| 2 | 2021-04-30 | Moderna | |
| 3 | 2021-12-10 | Moderna | No |
| 4 | 2022-11-05 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-02 | Unsuccessful | |
| 2022-12-02 | Unsuccessful |
Free text
Release 7 — day 21, dose 1
Symptoms: Tested positive for COVID, fatigue, headache, chills, difficulty focusing, body aches, loss of appetite, diarrhea
Release 11 — 12 months, dose 2
Symptoms: Got COVID again
Release 12 — day 21, dose 4
Symptoms: Tested positive for COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Disturbance in attention | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release